Alpha Profiles · Company Profile

Stoke Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/stoke-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: STOK
Verification: Partially verified
Last reviewed: 2026-09-13T04:45:57.604557+00:00

Overview

Alpha's canonical identity and public leadership record for Stoke Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

7 public records

Barry S. Ticho

Chief Medical Officer

State: confirmed
Effective: From Apr 22, 2026
Confidence: 94%
Evidence: STOK DEF 14A executive officersApr 22, 2026

Barry S. Ticho, M.D., Ph.D., FACC

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-170362Apr 22, 2026

Ian F. Smith

Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-170362Apr 22, 2026

Jason Hoitt

Chief Patient Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-170362Apr 22, 2026

Jonathan Allan

General Counsel and Corporate Secretary

State: confirmed
Effective: From Apr 22, 2026
Confidence: 94%
Evidence: STOK DEF 14A executive officersApr 22, 2026

Jonathan Allan, J.D.

General Counsel and Corporate Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-170362Apr 22, 2026

Thomas E. Leggett

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-170362Apr 22, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.